Cadence

The Umvuzo tech ecosystem is strong.
Filling this one gap would make it bulletproof.

Keeping members in rhythm with their care.

Access the Demo
The business case

What's Working

  • Healthy MeWearables, DNA, microbiome — predictive care for Activator members
  • Rx Health / 360 PlatformClaims, admin, clinical dashboards — built by your co-founders
  • Digital PlatformVirtual GP consultations, app-based access across all options
  • 50%+ SolvencyFinancially sound, room to invest in what compounds

The Gap

  • Healthy Me predicts risk for younger, healthier Activator members.
  • But your highest-cost members — dual-diagnosis CDL patients on Standard, Supreme, Extreme — are managing ART + metformin through fax-based registration and fragmented clinic visits.
  • They don't need prediction. They need daily coordination.
  • That layer — between the member's WhatsApp and the nurse's dashboard — doesn't exist yet.
Evidence in Hand

What We Know

All numbers modelled from published South African data. Real figures come from a pilot with your claims.

The Data

  • 39% medication adherenceAmong SA diabetes patients (Owolabi & Ajayi, 2024)
  • 4.5% to 12.7%Diabetes prevalence rose in SA (2010-2019)
  • ~R300K/yearRenal dialysis endpoint — per patient
  • ~R22K/patient/yearNon-adherence compounding cost (transport, wages, duplicate scripts, avoidable admissions)
  • 9% vs 4.4%Healthcare spend growth vs. contribution growth (CMS)

What We'd Need From You

  • Actual dual-diagnosis (HIV + diabetes/hypertension) count across your book
  • Current script pick-up rate and average clinic visits per CDL member
  • Claims cost distribution — top 5% of chronic members vs. average
  • Rx Health / 360 Platform integration architecture (FHIR readiness?)
  • Appetite for a 50-person employee-dependents pilot

We're not here with answers. We're here with a hypothesis and the tooling to test it — together, in 30 days, with your data.

Three Scenarios

Scaled to What We Validate

All numbers modelled from published SA data. Real figures come from a pilot with your claims.

Low Road
R5.5M
projected annual savings
Patients500
Script pickup65% → 73%
Avoided admissions25
Pilot investmentR800K
ROI6.9×
Cautious: smallest plausible CDL cohort, modest gains
Base Case
R20M
projected annual savings
Patients1,200
Script pickup65% → 80%
Avoided admissions72
Pilot investmentR1.5M
ROI13×
Published evidence median applied to your member profile
High Road
R44M
projected annual savings
Patients2,000
Script pickup65% → 83%
Avoided admissions140
Pilot investmentR3M
ROI15×
Full cohort, strong adoption, prevention of downstream renal cases

30 days. 50 patients. Your employee dependents.

We build the layer, you own the data. If the numbers don't hold, we walk away and you've lost nothing.

See the Platform